Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers. Developing biomarkers for early detection and chemotherapeutic response prediction is crucial to improve the dismal prognosis of PDAC patients. However, molecular cancer signatures based on transcriptome analysis do not reflect...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cells
Autores principales: Mahajan, Ujjwal Mukund, Alnatsha, Ahmed, Li, Qi, Oehrle, Bettina, Weiss, Frank-Ulrich, Sendler, Matthias, Distler, Marius, Uhl, Waldemar, Fahlbusch, Tim, Goni, Elisabetta, Beyer, Georg, Chromik, Ansgar, Bahra, Markus, Klein, Fritz, Pilarsky, Christian, Grützmann, Robert, Lerch, Markus M., Lauber, Kirsten, Christiansen, Nicole, Kamlage, Beate, Regel, Ivonne, Mayerle, Julia
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8305839/
https://ncbi.nlm.nih.gov/pubmed/34359990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10071821
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares